Deutsche Bank Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Deutsche Bank analyst Falko Friedrichs maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €44.00.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Friedrichs is an analyst with an average return of -2.7% and a 40.38% success rate. Friedrichs covers the Healthcare sector, focusing on stocks such as Siemens Healthineers AG, SCHOTT Pharma AG & Co. KGaA, and Fresenius Medical Care AG & Co. KGaA.
In addition to Deutsche Bank , Fresenius Medical Care AG & Co. KGaA also received a Hold from Barclays’s Hassan Al-Wakeel in a report issued yesterday. However, on the same day, Bank of America Securities maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (LSE: 0H9X).
0H9X market cap is currently €11.12B and has a P/E ratio of 12.32.
Read More on GB:0H9X:
Disclaimer & DisclosureReport an Issue
- Fresenius Medical reports Q4 EPS ex-items EUR1.44 vs. EUR0.91 last year
- Fresenius Medical sees 2026 revenue growth flat vs. EUR19.63B in 2025
- Sell Rating on Fresenius Medical Care Amid Unsustainable Earnings Quality and Structural Headwinds
- 0H9X Earnings this Week: How Will it Perform?
- Fresenius Medical price target lowered to EUR 36 from EUR 37 at Morgan Stanley
